Description
ActiCand® 30
Useful product both in the treatment and in the prevention of candida vulvovaginitis and related symptoms, in case of both acute episode (VVC) and relapsing forms (VVCR).
The formulation, thanks to the presence of citric acid and sodium bicarbonate and its peculiar formulation in slow disintegration vaginal tablets, is able to create a temporary physical barrier to oxygen inside the lumen of the vagina following the development of carbon dioxide ( CO2).
In this way, an almost anaerobic environment is formed due to the process of physical exclusion of the oxygen molecules.
This characteristic is able, in turn, to counteract the establishment, persistence or propagation of a vaginal candida infection.
In this way, a barrier effect is determined against the yeasts of the candida genus, responsible for most of the vulvovaginitis in women.
Furthermore, the presence of the two microorganisms Lactobacillus fermentum LF 10 and Lactobacillus acidophilus LA 02 mediates a strengthening of the physical barrier action mentioned above with a mechanism that turns out to be ancillary to that of citric acid, sodium bicarbonate.
Finally, the slight effervescence conveys the lactobacilli throughout the vaginal lumen, favoring their dispersion.
It also contains a suitable quantity of fructo-oligosaccharide fibers (FOS) and arabinogalactan, capable of accelerating the onset of the positive effects ascribable to the two lactobacilli of the formulation.
How to use:
Candida vulvovaginitis (VVC): One vaginal tablet per day to be applied as deep as possible into the vagina, preferably in the evening before bedtime. This treatment should be carried out for 5 days and then prolonged with one vaginal tablet every three days for the next three vaginal tablets.
Relapsing forms of Candida Vulvovaginitis (VVCR): One vaginal tablet every two days to be applied as deep as possible into the vagina, preferably in the evening before bedtime. this treatment must be carried out for 10 days and then prolonged with one vaginal tablet a week for the following three vaginal tablets.
As a preventive measure, it is recommended to use one vaginal tablet a week for the next eight weeks. Do not take the product by mouth.
Components:
One tablet contains: Citric acid. Sodium bicarbonate. Lactobacillus fermentum LF 10 (DSM 19187): no less than 400 million live lactobacilli. Lactobacillus acidophilus LA 02 (DSM 21717): no less than 400 million live lactobacilli. Fructo-oligosaccharides (FOS): 332 mg. Arabinogalactan, 273 mg.
Ingredients:
Microcrystalline cellulose. Anhydrous calcium hydrogen phosphate. Glyceryl behenate. Sucrose palmitate. Silicon dioxide (anti-caking agent).
Magnesium stearate.
Reviews
There are no reviews yet.